- About Us
- Our Research
- Diseases and conditions
- Research Groups
- Research support and facilities
- Aboriginal and Torres Strait Islander Health
- Participate in our research
- Research history
- Glossary of research terms
- Support Us
- Why support QIMR Berghofer?
- Ways to help
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- News & Events
- Contact Us
- Our Services
- CMV study
- Queensland Pancreatic Cancer Study
- QIMR Berghofer Centre for Immunotherapy and Vaccine Development
SummaryThe Immunology and Infection Laboratory studies the host immune response during malaria and leishmaniasis. Our aim is to distinguish anti-parasitic host immune responses that control infection from those that cause disease. We use experimental models, as well as samples from patients and human volunteers deliberately infected with parasites for our research. The long term goal of our research is to develop better vaccines and therapies to prevent and treat infectious diseases.
- Understanding how T cells behave during malaria and leishmania.
- Identifying how T cells are regulated during malaria and leishmania.
- Investigating novel immune pathways activated during malaria and leishmania.
Group Leader: Dr Christian R. Engwerda
Postdoctoral Research Officers: Dr Fiona H. Amante, Dr Meru Sheel, Dr Rajiv Kumar
Research Assistant: Fabian de Labastida Rivera
PhD students: Patrick Bunn, Marcela Montesdeoca, Priyadarshini Faleiro.
We gratefully acknowledge the support of the following funding agencies:
- The National Health and Medical Research Council
- QIMR Centre for Immunotherapy and Vaccine Development
- The Wellcome Trust
- John and Betty Ohye
Professor Paul Kaye, London School of Hygiene and Tropical Medicine, UK.
Professor Shyam Sundar, Banaras Hindu University, Varanasi, India.
Professor Nicholas M. Anstey, Menzies School of Health Research, Darwin, Australia.
Professor William R. Heath, Department of Microbiology and Immunology, University of Melbourne, Australia.